leisure time -WSS

leisure time

author：hotspot 2025-09-30 01:01:22 - browse：19226

Kara Coluccio, a managing partner at Perspective Group poses for a portrait. -- health coverage from STAT — Kara Coluccio, a managing partner at Perspective Group, says the job market for biotech executives has gotten much tighter. Jessica Rinaldi/Globe Staff

When Crystal Shih Byers left her job at Novartis in 2020, she was excited to make the leap into a smaller startup.

Byers had spent almost nine years at Novartis, most recently helping lead a group that worked on gene therapy. But pharmaceutical companies are large and complex, and she craved more immediate impact. “I was looking for a place where I could be in the room,” she says. She wanted more autonomy, and to feel like her work would reach patients sooner.

At the time, biotech startups were rolling in cash and seeking to capture some of the magic that had fueled Moderna’s meteoric rise. They handed out lots of logo-embossed swag. “Investors were putting a lot of money into stupid science,” Byers says. “There were a lot of companies that lasted for a lot longer than I thought they would on very little data.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： NYU Langone launches private ChatGPT for its health care data

hotspot

WSS

Why Charlie Gard's case is so disturbing to Americans

Appeals court upholds limits to abortion pill

How to make Best Hospitals ratings actually useful for patients

Sana to lay off nearly a third of staff, de

AI can decode, harness the power of the humane immune system

How to make AI work for medicine

focus

leisure time

focus

Affirmative action in medical school literally saved lives

Feds fine Medicare Advantage plans for overcharging members

Tori Bowie and the unacceptable rates of Black maternal death

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

As demand for Covid shots wanes, Moderna seeks its next success

Senate panel eyes new effort on drug shortages

Cancer drug shortages should be causing more outrage

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sana to lay off nearly a third of staff, de

hotspot

AstraZeneca bets AAV gene therapy will still deliver the goods

AI can decode, harness the power of the humane immune system

Neuroscience startup Neumora files for IPO

Bill would stop addiction treatment from triggering child abuse inquiry

Stroke deaths set to near 10 million globally by 2050

Radiation, mainstay of cancer treatment, begins a fade

leisure time

Wikipedia

hotspot

hotspot